Cargando…
CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome
Identification of new markers associated with long-term efficacy in patients treated with CAR T cells is a current medical need, particularly in diseases such as multiple myeloma. In this study, we address the impact of CAR density on the functionality of BCMA CAR T cells. Functional and transcripti...
Ejemplares similares
-
Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia
por: Calviño, Cristina, et al.
Publicado: (2023) -
In vivo CRISPR-Cas9 inhibition of hepatic LDH as treatment of primary hyperoxaluria
por: Martinez-Turrillas, Rebeca, et al.
Publicado: (2022) -
Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells
por: Martín-Otal, Celia, et al.
Publicado: (2022) -
CAR T-Cells in Multiple Myeloma Are Ready for Prime Time
por: Rodríguez-Otero, Paula, et al.
Publicado: (2020) -
Uncovering perturbations in human hematopoiesis associated with healthy aging and myeloid malignancies at single-cell resolution
por: Ainciburu, Marina, et al.
Publicado: (2023)